Sep 8, 2020   SOURCE: PR NewsWire

United States Alzheimer's Disease - Industry Outlook to 2025

DUBLIN, Sept. 8, 2020 /PRNewswire/ -- The "US Alzheimer's Disease Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The report provides comprehensive insights into Alzheimer's Disease pipeline products, Alzheimer's Disease epidemiology, Alzheimer's Disease market valuations and forecast, Alzheimer's Disease drugs sales and competitive landscape in the US.

The research is classified into seven sections - Alzheimer's Disease treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

    --  Alzheimer's Disease pipeline: Find out the products in clinical trials
        for the treatment of Alzheimer's Disease by development phase 3, phase
        2, and phase 1, by pharmacological class and companies developing the
        products
    --  Alzheimer's Disease epidemiology: Find out the number of patients
        diagnosed (prevalence) with Alzheimer's Disease in the US
    --  Alzheimer's Disease drugs: Identify key products marketed and prescribed
        for Alzheimer's Disease in the US, including trade name, molecule name,
        and company
    --  Alzheimer's Disease drugs sales: Find out the sales revenues of
        Alzheimer's Disease drugs in the US
    --  Alzheimer's Disease market valuations: Find out the market size for
        Alzheimer's Disease drugs in 2019 in the US. Find out how the market
        advanced from 2016 and forecast to 2025
    --  Alzheimer's Disease drugs market share: Find out the market shares for
        key Alzheimer's Disease drugs in the US

Benefits of this Research

    --  Support monitoring and reporting national Alzheimer's Disease market
        analysis and sales trends
    --  Track competitor drugs sales and market share in the US Alzheimer's
        Disease market
    --  Track competitive developments in Alzheimer's Disease market and present
        key issues and learnings
    --  Synthesize insights for Alzheimer's Disease market and products to drive
        business performance
    --  Answer key business questions about the Alzheimer's Disease market
    --  Evaluate commercial market opportunity assessment, positioning, and
        segmentation for Alzheimer's Disease products
    --  Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Alzheimer's Disease Treatments
2) Alzheimer's Disease Pipeline
3) US Alzheimer's Disease Epidemiology
4) Marketed Drugs for Alzheimer's Disease in US
5) US Alzheimer's Disease Market Size and Forecast
6) US Alzheimer's Disease Products Sales and Forecast
7) US Alzheimer's Disease Market Competitive Landscape
8) Methodology

List of Tables
1. Alzheimer's Disease Phase 3 Clinical Trials, 2019
2. Alzheimer's Disease Phase 2 Clinical Trials, 2019
3. Alzheimer's Disease Phase 1 Clinical Trials, 2019
4. Alzheimer's Disease Epidemiology, US, 2016-2025
5. Marketed Drugs for Alzheimer's Disease, US, 2018
6. Alzheimer's Disease Market Size and Forecast ($), US, 2016-2025
7. Alzheimer's Disease Product Sales ($), US, 2016-2025

List of Figures
1. Alzheimer's Disease Epidemiology, US, 2016-2025
2. Alzheimer's Disease Market Size and Forecast ($), US, 2016-2025
3. Alzheimer's Disease Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/yyquti

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/united-states-alzheimers-disease---industry-outlook-to-2025-301125525.html

SOURCE Research and Markets